Revolutionizing Biomedical Science with Explainable AI Advances

Date:

Machine learning and artificial intelligence (AI) have been making significant advancements in various scientific fields in recent years, leading to groundbreaking discoveries. Biomedicine, the application of biological principles to healthcare technologies, has greatly benefited from the combination of these technologies. Through the use of AI algorithms, machine learning plays a crucial role in developing accurate models to support physicians in making informed decisions.

To address the need for transparency in AI-based biomedical decisions, explainable artificial intelligence techniques are being developed. These techniques allow physicians to understand the decisions made by the AI models they utilize, ensuring a collaborative approach to patient care.

The second volume of the Machine Learning and Artificial Intelligence for Biomedical Applications Special Issue focuses on the latest research in this field. Researchers are invited to submit their manuscripts for publication in the Bioengineering journal, where accepted papers will be published online upon approval.

Manuscripts must be original and not under consideration for publication elsewhere. A single-blind peer-review process ensures the quality of submissions, with accepted papers listed on the special issue website. Authors are encouraged to adhere to the Instructions for Authors provided by MDPI, the publisher of Bioengineering.

To support open access publishing, authors are required to pay an Article Processing Charge (APC) of 2700 CHF (Swiss Francs) upon acceptance of their manuscript. English editing services are available to help authors prepare their papers for publication.

As the field of biomedicine continues to evolve with the integration of AI and machine learning, researchers play a crucial role in advancing healthcare technologies. By promoting collaboration between AI technologies and healthcare professionals, the future of biomedicine looks promising with improved patient outcomes and innovative solutions for complex medical challenges.

See also  Oak Ridge National Laboratory Joins Global Consortium for Advancing Large-Scale AI Models in Scientific Discovery, US

Frequently Asked Questions (FAQs) Related to the Above News

What is the focus of the Machine Learning and Artificial Intelligence for Biomedical Applications Special Issue?

The special issue focuses on the latest research in the field of biomedicine, particularly the integration of AI and machine learning technologies for healthcare advancements.

How can researchers submit their manuscripts for publication in the Bioengineering journal?

Researchers can submit their original manuscripts for publication in the Bioengineering journal by following the submission guidelines provided by MDPI.

What is the Article Processing Charge (APC) for authors to publish their manuscript?

Authors are required to pay an Article Processing Charge (APC) of 2700 CHF (Swiss Francs) upon acceptance of their manuscript for publication.

Are English editing services available to help authors prepare their papers for publication?

Yes, English editing services are available to assist authors in preparing their manuscripts for publication in the Bioengineering journal.

How are submissions evaluated for publication in the special issue?

Submissions undergo a single-blind peer-review process to ensure the quality and relevance of the research. Accepted papers will be listed on the special issue website.

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.